AI and quantum science power new 'Made-for-You' brain cancer vaccine trial
NCT ID NCT07077616
Summary
This early-phase study is testing a new, personalized vaccine called TAMAVAQ for adults with newly diagnosed glioma, a type of brain cancer. The vaccine is custom-made for each patient using their own tumor and advanced computer modeling (AI and quantum mechanics) to try to train their immune system to attack the cancer. The main goals are to see if the vaccine is safe and to look for early signs that it might help control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Biogenea Pharmaceuticals Ltd
RECRUITINGThessaloniki, 54627, Greece
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.